000 01407 a2200385 4500
005 20250517214857.0
264 0 _c20190701
008 201907s 0 0 eng d
022 _a1664-3224
024 7 _a10.3389/fimmu.2018.00925
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPegoretti, Valentina
245 0 0 _aSelective Modulation of TNF-TNFRs Signaling: Insights for Multiple Sclerosis Treatment.
_h[electronic resource]
260 _bFrontiers in immunology
_c2018
300 _a925 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAutoimmunity
_xdrug effects
650 0 4 _aBiomarkers
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xpharmacology
650 0 4 _aImmunomodulation
_xdrug effects
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMultiple Sclerosis
_xdrug therapy
650 0 4 _aNeuroprotective Agents
_xpharmacology
650 0 4 _aReceptors, Tumor Necrosis Factor
_xmetabolism
650 0 4 _aRegeneration
_xdrug effects
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTumor Necrosis Factors
_xmetabolism
700 1 _aBaron, Wia
700 1 _aLaman, Jon D
700 1 _aEisel, Ulrich L M
773 0 _tFrontiers in immunology
_gvol. 9
_gp. 925
856 4 0 _uhttps://doi.org/10.3389/fimmu.2018.00925
_zAvailable from publisher's website
999 _c28390823
_d28390823